Évaluation et validation des tests diagnostiques dans le cadre du ciblage thérapeutique-Reference-Cited by-同舟云学术

Évaluation et validation des tests diagnostiques dans le cadre du ciblage thérapeutique

Published:2009-05 Issue:3 Volume:64 Page:187-194
ISSN:0040-5957
Container-title:Therapies
language:fr
Short-container-title:Therapies

Author:

Landais Paul,Méresse Valérie,Ghislain Jean-Claude,Arnaud Olivier,Bibeau Frédéric,Cellier Dominic,d’Enfert Jérôme,Eberlé Frédéric,Goestchel Agnès,Grognet Jean-Marc,Janus Catherine,Kassaï-Koupaï Behrouz,Laurent-Puig Pierre,Maisonneuve Pascale,Nowak Frédérique,Paintaud Gilles,Robba Laurence

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference18 articles.

1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working Group;Clin Pharmacol Ther,2001

2. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer;Vogel;J Clin Oncol,2002

3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

4. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group;Marty;J Clin Oncol,2005

5. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Green Sustainable Nanoparticles as a Drug Delivery System—An Updated Review;Sustainable Materials and Technology;2024

2. Single-Cell Omics: Strategies Towards Theranostic Biomarker Discovery Along the Continuum of Premalignant to Invasive Disease in Oncology;Single-Cell Omics;2019

3. Synthesis and cytotoxicity study of novel 3-(triazolyl)coumarins based fluorescent scaffolds;Bioorganic & Medicinal Chemistry Letters;2016-11

4. Theranostics in primary care: pharmacogenomics tests and beyond;Expert Review of Molecular Diagnostics;2012-11

5. Best practices for companion diagnostic and therapeutic development: translating between the stakeholders;New Biotechnology;2012-09